Verve Ventures, based in Baar-Zug, Switzerland, is an investment firm backing deep-tech startups in Europe.
Founded in 2010 in Baar-Zug, Switzerland, Verve Ventures invests in deep-tech startups and provides funding and strategic support. Portfolio companies named in its profile include Memo Therapeutics, developing therapeutic antibodies, Axelera, an AI hardware and software platform, and Neustark, which stores CO2 in concrete. The firm has completed three deals. Its latest round, on August 19, 2016, raised CHF 3.5 million from Zürcher Kantonalbank and other investors. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in